NCT03221400 2022-02-17
PEN-866 in Patients With Advanced Solid Malignancies
Tarveda Therapeutics
Phase 1/2 Unknown
Tarveda Therapeutics
Georgetown University
The Netherlands Cancer Institute
Hellenic Oncology Research Group
National University Hospital, Singapore
Mast Therapeutics, Inc.
Seattle Cancer Treatment and Wellness Center